Skip to main content
. 2017 Jul 17;11:205. doi: 10.3389/fncel.2017.00205

Figure 2.

Figure 2

Effects of BMSC-EVs on 5 min of bilateral common carotid artery occlusion-induced COX-2 expression at mRNA and protein levels in the hippocampi. Intracerebroventricular injection (ICVI) of 200 μg BMSC-EVs right before occlusion largely suppressed pathogenic expression of COX-2 at (A) mRNA level (sham + EV = 96 ± 4, ischemia = 5.7 ± 1.5, ischemia + EV = 2.2 ± 0.7) and (B) protein level (sham + EV = 1.2 ± 0.15, ischemia = 341 ± 39, ischemia + EV = 128 ± 10). n = 8 tests per group. Data show means ± SEM. One-way ANOVA analysis followed by a Tukey’s post hoc test. **p < 0.01 and ***p < 0.001.